Vital Signs - Recent Acquisitions Shape Up New Competitive Landscape in Speech and Transcription Industry

 

Regular Price: USD 1,500

Special Price USD 1,125

25% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,125

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on February 14, 2012, provides a strategic insight on the speech and transcription industry.

Additionally, a company spotlight is provided for Mach 7 Technologies (M7T). As a vendor neutral archive (VNA) partner, M7T helps healthcare enterprises worldwide resolve complex integration issues between PACS vendors, consolidate DICOM and non-DICOM image data, reduce the time it takes to bring new PACS live through an intelligent migration, and save money with the capabilities of Keystone Suite.

Reimbursement and regulatory news from the FDA is also provided for week of January 30, 2012.

Table of Contents

Vital Signs - Recent Acquisitions Shape Up New Competitive Landscape in Speech and Transcription IndustryVital Signs: 14 February 2012This week's issue




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.